Neoadjuvant low-dose radiotherapy plus durvalumab and chemotherapy for potentially resectable stage III NSCLC: A phase Ib dose-escalation study
| Autor: | Li, Juan, Lu, Shun, Tian, Yuke, Jiang, Lan, Li, Lu, Xie, Shao-Hua, Li, Qiang |
|---|---|
| Zdroj: | In Radiotherapy and Oncology July 2024 196 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect